ART4 and infection: As HCV vaccine candidates progress, standardized in vitro assays to study and compare immune responses after natural infection and vaccination, using a representative panel of the antigenic diversity of HCV glycoprotein E1E2 to evaluate immunological responses, are increasingly relevant.